Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026

Go back to Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026
(NASDAQ: IPSC) Delayed: 2.17 +0.02 (0.93%)
Previous Close $2.15    52 Week High
Open $2.10    52 Week Low
Day High $2.18    P/E N/A 
Day Low $2.10    EPS
Volume 519,932